A real estate executive and a microbiologist have teamed up to try to increase rapid COVID-19 testing in Canada

    A U.K. doctor takes a blood sample to test a patient for COVID-19 antibodies. Shutterstock/Cryptographer

    A biotech conglomerate led by Canadian real estate investors has developed a rapid COVID-19 test they believe can help governments lift lockdowns and businesses reopen. 

    Tridan/CBS claims its device, called the Zekmed, can detect antibodies for active infections and those from which patients have recovered. If approved by Health Canada, it would be among the first Canadian rapid tests on the market. 

      Purchase a subscription to read the full article.

      By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.
      Already a subscriber?